Australian shares were down today, pulled in that direction by a weaker tech sector.
The bourse dropped 18.90 points or 0.24% to 7,748.60 and crossed below its 20-day moving average.
Flunking out at 3:30pm were Strike Energy Ltd and Pro Medicus Ltd, down 16.96% and 5.59% respectively.
The index has lost 0.61% for the last five days and sits 2.05% below its 52-week high.
Across the sectors, it was a mixed bag this afternoon. Energy, Materials and Real Estate beat the general downward trend, up 0.35%, 1.02% and 0.88% respectively, while at the other end, Information Technology was a drag on the markets, falling 2.21%.
Taking a Tryp to safety
Tryptamine Therapeutics Ltd has successfully completed the first dosing of TRP-8803, an intravenous-infused psilocin, in a groundbreaking psychedelic treatment study. Conducted with CMAX Clinical Research in Adelaide, this trial aims to optimise dosing and infusion rates in up to 12 participants to achieve precise blood levels of psilocin.
The study's results will inform Tryp's Phase 2a patient study pipeline, ensuring the safety and efficacy of TRP-8803 in humans.
The successful first dosing has increased confidence in TRP-8803's potential as a psychedelic therapy. The trial is set to conclude later in the year, with results to be reported thereafter. Positive findings could advance Tryptamine's clinical trial pipeline for various conditions.
"Tryp CEO Jason Carroll said: “We are very pleased to have completed the world’s first TRP-8803 treatment in a patient in Adelaide. Pleasingly, the maiden participant was delivered the infusion safely and was discharged on treatment conclusion, which provides management with confidence of TRP-8803 and the completion of this healthy human volunteer study.
“The trial, which being undertaken alongside CMAX is an incredibly important initiative for Tryp, as it will provide us with data highlighting TRP-8803’s safety in humans at escalating doses.
"This will form the basis of the company’s clinical trial pipeline into other indications and ultimately our regulatory engagement."
Sales of new homes down in US
New US housing and construction data might point to softening inflation in that country. Sales of newly built homes fell 11.3% in May to 619,000, the lowest since November, according to US Government data.
This was the steepest decline since September 2022 and reflects the challenges in a market where new homes make up 10% of total sales.
Economists had projected 647,500 sales for May, but elevated mortgage rates, which peaked early in the month, contributed to the decline. Although rates have since trended down, they remain high, affecting buyer decisions.
Federal Reserve officials expect only a slight easing of borrowing costs this year, with just one rate cut anticipated.
Significant relief in mortgage rates depends on inflation moving closer to the Fed's 2% target, and there is a possibility that rates may not be cut at all this year.
The five at five
Lindian Resources Kangankunde feasibility study confirms very low-cost project with 45-year mine life; shares up
Lindian Resources Ltd (ASX:LIN, OTC:LINIF) is trading higher after completing a feasibility study for Stage 1 development of the Kangankunde Rare Earths Element (REE) Project in Malawi, confirming a low-risk and economically robust project.
Read more
Anson Resources takes delivery of Li-Pro™ lithium process pilot unit at Green River
In a key step toward commercial production at the Green River Lithium Project in Utah, USA, Anson Resources Ltd has taken delivery of the Koch Technology Solutions (KTS) Li-Pro™ process pilot unit for lithium extraction tests using brine from the project.
Read more
Anteris Technologies reaches concept lock of first phase of Transcatheter Edge to Edge Repair system for heart disease
Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) and technology partner v2vmedtech, inc have reached the concept lock stage on the first phase of development for the next generation Transcatheter Edge to Edge Repair (TEER) system for mitral and tricuspid valve regurgitation.
Read more
Peninsula Energy progresses Lance site preparations ahead of uranium production restart this year
Plant construction and wellfield development activities at the Lance Uranium Project of Peninsula Energy Ltd in Wyoming, USA, are on schedule and within budget ahead of a planned production restart later this year.
Read more
Sunstone Metals taps specialist resources financial executive Lucas Welsh for CFO role
Sunstone Metals Ltd (ASX:STM) has appointed specialist resources financial executive Lucas Welsh (CA, MBA, GAICD) as chief financial officer (CFO) and company secretary, effective today.
Read more
On your six
Big Four and their customers under constant cyber attack
National Australia Bank (NAB) executive for group investigations Chris Sheehan warns that Australia's major banks are under relentless cyber-attacks, placing the entire community at risk.
Read more
The one to watch
Antipa Minerals secures $5.75 million to fund Minyari Dome endeavours
Antipa Minerals Ltd (ASX:AZY) managing director Roger Mason joins Proactive’s Jonathan Jackson to talk about funding and plans for its Minyari Dome Project.
Watch